Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
Strongbridge Biopharma plc (SBBP) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/05/2022 SC 13D/A CAXTON CORP reports a 0% stake in Strongbridge Biopharma plc
10/25/2021 SC 13D/A Growth Equity Opportunities Fund III, LLC has filed a Schedule 13D for Strongbridge Biopharma plc
10/15/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
10/07/2021 EFFECT Form EFFECT - Notice of Effectiveness:
10/07/2021 EFFECT Form EFFECT - Notice of Effectiveness:
10/07/2021 EFFECT Form EFFECT - Notice of Effectiveness:
10/05/2021 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/05/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/05/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/05/2021 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc."
09/13/2021 425 Form 425 - Prospectuses and communications, business combinations:
09/08/2021 8-K Quarterly results
08/31/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/30/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/30/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/30/2021 8-K Quarterly results
08/30/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/30/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/26/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/26/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/12/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/06/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/05/2021 10-Q Quarterly Report for the period ended June 30, 2021
08/05/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/05/2021 8-K Quarterly results
08/02/2021 425 Form 425 - Prospectuses and communications, business combinations:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy